EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Adult and pediatric physiologically‐based biopharmaceutics modeling to explain lamotrigine immediate release absorption process

Edilainy Rizzieri Caleffi-Marchesini, Amanda Antunes Herling, Julia Macente, Rodolfo Hernandes Bonan, Priscila de Freitas Lima, Rafaela Moreno, Veriano Alexandre, Nitin Bharat Charbe, Fernanda Belincanta Borghi-Pangoni, Rodrigo Cristofoletti iD, Andréa Diniz iD

CPT: Pharmacometrics & Systems Pharmacology · 2024

DOI: 10.1002/psp4.13071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, 2024. Verfasst von Edilainy Rizzieri Caleffi-Marchesini und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacokinetics and Biopharmaceutics Laboratory, State University of Maringá, Maringá, PR, Brazil. Hauptthemen laut MEDLINE: Biopharmaceutics, Intestinal Absorption. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Coordination of Superior Level Staff Improvement, Araucaria Foundation, Fundacion Araucaria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Physiologically‐based biopharmaceutics modeling (PBBM) has potential to accelerate the development of new drug and formulations. An important application of PBBM is for special populations such as pediatrics that have pharmacokinetics dependent on the maturation process. Lamotrigine (LTG) is a Biopharmaceutics Classification System (BCS) II drug and is widely prescribed. Therefore, the goal of this study was to assess the biopharmaceutics risk of the low‐soluble drug LTG when the ontogeny on gastrointestinal tract (GIT) physiological parameters are considered. An oral physiologically‐based pharmacokinetic model and a PBBM were developed and verified using GastroPlus™ software for both adults and children (2–12 years old, 12–52 kg). The biopharmaceutics properties and GIT physiological parameters were evaluated by sensitivity analysis. High doses were simulated assuming a worst case scenario, that is, the dose of 200 mg for adults and 5 mg/kg (up to the maximum of 200 mg) for 2‐year‐old children. Although several authors have suggested that ontogeny may have an effect on gastrointestinal fluid volume, our study found no evidence of interference between fluid and dose volumes with in vivo dissolution of LTG. The most impactful parameter was found to be the gastric transit time. Therefore, the hypothesis is developed to examine whether LTG exhibits characteristics of a BCS II classification in vitro while showing BCS I–like behavior in vivo. This hypothesis could act as a base for conducting novel studies on model‐informed precision dosing, tailored to specific populations and clinical conditions. In addition, it could be instrumental in assessing the influence of various release profiles on in vivo performance for both adult and pediatric populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiopharmaceuticsIntestinal AbsorptionAdultHumansChildChild, PreschoolLamotrigineSolubilityDrug CompoundingAdministration, OralModels, Biological

Substanzen

Lamotrigine

Autor:innen und Institutionen

  • Pharmacokinetics and Biopharmaceutics Laboratory, State University of Maringá, Maringá, PR, Brazil.
  • Centro Universitário Barão de Mauá, Ribeirão Preto, SP, Brazil.
  • Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
  • Center for Pharmacometrics & Systems Pharmacology, University of Florida, Orlando, Florida, USA.

ORCID-Profile: Rodrigo Cristofoletti, Andréa Diniz

Förderung

  • Coordination of Superior Level Staff Improvement
  • Araucaria Foundation
  • Fundacion Araucaria

Zitieren

APA

Caleffi-Marchesini, E. R., Herling, A. A., Macente, J., Bonan, R. H., de Freitas Lima, P., Moreno, R., Alexandre, V., Charbe, N. B., Borghi-Pangoni, F. B., Cristofoletti, R., & Diniz, A. (2024). Adult and pediatric physiologically‐based biopharmaceutics modeling to explain lamotrigine immediate release absorption process. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.13071

Vancouver

Caleffi-Marchesini ER, Herling AA, Macente J, Bonan RH, de Freitas Lima P, Moreno R, et al. Adult and pediatric physiologically‐based biopharmaceutics modeling to explain lamotrigine immediate release absorption process. CPT: Pharmacometrics & Systems Pharmacology. 2024. doi:10.1002/psp4.13071

BibTeX
@article{CaleffiMarchesini2024,
  author = {Caleffi-Marchesini, Edilainy Rizzieri and Herling, Amanda Antunes and Macente, Julia and Bonan, Rodolfo Hernandes and de Freitas Lima, Priscila and Moreno, Rafaela and Alexandre, Veriano and Charbe, Nitin Bharat and Borghi-Pangoni, Fernanda Belincanta and Cristofoletti, Rodrigo and Diniz, Andréa},
  title = {Adult and pediatric physiologically‐based biopharmaceutics modeling to explain lamotrigine immediate release absorption process},
  journal = {CPT: Pharmacometrics & Systems Pharmacology},
  year = {2024},
  doi = {10.1002/psp4.13071}
}
Kostenlos starten →